Table 2. Comparison of biochemical findings of groups.
| Variable | Control group | ATRA group | ATRA+CP group | CP group |
|---|---|---|---|---|
| TAS (µmol Trolox equivalent/g) | 19.59±0.79 | 20.67±0.74 | 19.83±1.02 | 20.55±1.67 |
| TOS (µmol H2O2 equivalent/g) | 0.03 (0.02–0.05) | 0.03 (0.02–0.05) | 0.04 (0.03–0.06) | 0.06 (0.03–0.09)a,b,c |
| OSI | 0.15 (0.09–0.25) | 0.13 (0.09–0.24) | 0.18 (0.14–0.29)b | 0.25 (0–0.5)a,b,c |
| Testicular damage score | 0 (0–0) | 0 (0–0) | 1 (0–2) | 2 (1–2)a,b,c |
| Johnsen score | 10 (10–10) | 10 (10–10) | 8 (6–8)a,b | 5 (4–6)a,b,c |
Values are presented as mean±standard deviation or median (range).
ATRA: all-trans retinoic acid, CP: cisplatin, TAS: total antioxidant status, TOS: total oxidant status, OSI: oxidative stress index.
ap<0.05 compared with control group. bp<0.05 compared with ATRA group. cp<0.05 compared with ATRA+CP group.